Shree Akshar Pharmaceuticals Private Limited, a active private limited company, was established on 04 October 1995 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230MH1995PTC093251. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹3.00 Cr and a paid-up capital of ₹2.38 Cr.
It upholds a compliant status. Employing 31 professional, Its leadership includes Jitendrakumar Narpatbhai Desai (Director), Sudhir Haribhai Patel (Director), Miteshbhai Rameshbhai Chaudhary (Additional Director). Past directors included Haresh Purnanad Trivedi, Girishbhai Faljibhai Patel, Haribhai Dhirubhai Patel. It holds ₹4.00 M open charges and ₹2.80 M settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Shop No13Jam Mill Bldg Lalbaug, Mumbai, Maharashtra, 400012.
U24230MH1995PTC093251
093251
04 October 1995
₹3.00 Cr
₹2.38 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Shree Akshar Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jitendrakumar Narpatbhai Desai | Director | 26 Mar 2002 | Current |
| Sudhir Haribhai Patel | Director | 04 Oct 1995 | Current |
| Miteshbhai Rameshbhai Chaudhary | Additional Director | 07 Jul 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 07 Jul 2021 | Past |
| Pramod Abcsdd | Director | 07 Jul 2021 | Past |
| Pramod Abcsdd | Director | 07 Jul 2021 | Past |
| Pramod Abcsdd | Director | 07 Jul 2021 | Past |
| Pramod Abcsdd | Director | 29 Apr 2014 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Shree Akshar Pharmaceuticals Private Limited, for the financial year ended 2020, experienced Minor drop in revenue, with a 6.43% decrease. The company also saw a substantial fall in profitability, with a 36.07% decrease in profit. The company's net worth Soared by an impressive increase of 10.77%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Shree Akshar Pharmaceuticals had a promoter holding of 12.60% and a public holding of 87.40%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹4,000,000.00
₹2,800,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Dec 2017 | Others | ₹4.00 M | Open |
| 09 Sep 1997 | Dena Bank | ₹2.80 M | Satisfied |
Explore comprehensive loan charge details -
Shree Akshar Pharmaceuticals has a workforce of 31 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Shree Akshar Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shree Akshar Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Shree Akshar Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
Shree Akshar Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was recorded as a recent event.
The activity Miteshbhai Rameshbhai Chaudhary was appointed as a Additional Director was appointed as a Additional Director on 07 Jul 2021 & has been associated with this company since 4 years 6 months . was completed.
Progress on A charge with Others amounted to Rs. 0.40 Cr with Charge ID 100143905 was registered on 28 Dec 2017. was documented.
The activity A charge registered on 09 Sep 1997 via Charge ID 90240366 with Dena Bank was fully satisfied on 23 Aug 2017. was completed.
A charge with Dena Bank of Rs. 0.28 Cr registered on 09 Sep 1997 with Charge ID 90240366 was modified on 24 Jan 2004. was recorded as a recent event.
The CIN of Shree Akshar Pharmaceuticals Private Limited is U24230MH1995PTC093251.
Shree Akshar Pharmaceuticals Private Limited is headquartered at Shop No13Jam Mill Bldg Lalbaug, Mumbai, Maharashtra, 400012.
Shree Akshar Pharmaceuticals Private Limited was incorporated on 04 October 1995.
The current directors of Shree Akshar Pharmaceuticals Private Limited are
The primary industry of Shree Akshar Pharmaceuticals Private Limited is Manufacturing.
Shree Akshar Pharmaceuticals Private Limited is unlisted.
The authorized capital of Shree Akshar Pharmaceuticals Private Limited is ₹3.00 Cr, and the paid-up capital is ₹2.38 Cr.
The compliance status of Shree Akshar Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX